Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. covers the period from September 1 to September 30, 2019. The report details consolidated transactions of securities and derivatives involving the company's Board of Directors, Management, and Related Persons, in compliance with Article 11 of CVM Instruction # 358/2002. The filing was signed on October 9, 2019.
Key Financial Metrics
The filing text does not provide company-wide financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly limited to reporting insider trading activity and security holdings.
| Category | Initial Balance (Shares) | Transactions (Sept 2019) | Final Balance (Shares) |
|---|---|---|---|
| Group and Related Persons | 34,109,031 Common 1,480,680 ADR |
No transactions reported | 34,109,031 Common 1,480,680 ADR |
| Board of Directors | 7,608,889 Common 302,785 ADR |
Bought: 170,535 Common Sold: 75,325 Common |
7,704,099 Common 302,785 ADR |
| Management | 7,225 Common | No transactions reported | 7,225 Common |
Material Changes
Material changes were observed only within the Board of Directors category during September 2019:
- Purchases: Two option exercise/subscription transactions occurred on September 23 (75,325 shares at R$ 9.3596) and September 30 (95,210 shares at R$ 11.9720), totaling 170,535 shares purchased for approximately R$ 1.84 million.
- Sales: One sale transaction occurred on September 23 for 75,325 shares at R$ 19.41, totaling approximately R$ 1.46 million.
- Net Change: The Board's common shareholding increased by 95,210 shares.
No changes were reported for the Group and Related Persons or Management categories.
Guidance, Outlook, and Risks
The filing text does not provide any guidance, outlook, management commentary on business performance, risks, contingencies, or unusual items. The document serves solely as a regulatory disclosure of insider securities transactions.
Investor Verification Checklist
- Verify the net increase of 95,210 common shares held by the Board of Directors.
- Confirm the specific dates and prices of the option exercises (Sept 23 and Sept 30) versus the sale (Sept 23).
- Note that no trading activity was reported for the broader Group and Related Persons or Management categories during this period.
- Recognize that this filing contains no operational or financial performance data for Ambev S.A.